These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4960848)

  • 41. [Methods of therapy of patients with chronic destructive pulmonary tuberculosis].
    Utkin VV; Rudoĭ NM
    Klin Med (Mosk); 1968 Dec; 46(12):36-43. PubMed ID: 5737381
    [No Abstract]   [Full Text] [Related]  

  • 42. [Th 13-14 and PZA and CS in the treatment of chronic cavitary tuberculosis with bacterial resistance to classic antibacterial drugs].
    Zunić D
    Tuberkuloza; 1966; 18(5):429-40. PubMed ID: 16296047
    [No Abstract]   [Full Text] [Related]  

  • 43. [Clinical research: course of pulmonary tuberculosis caused by polyresistant Mycobacterium tuberculosis].
    Daddi G; Lucchesi M; Mancini P; Matzeu M; Rossi P
    Ann Ist Carlo Forlanini; 1969; 29(4):330-8. PubMed ID: 5004331
    [No Abstract]   [Full Text] [Related]  

  • 44. [Complex research studies in the testing of the effectiveness of phenaside].
    Sel'tsovskiĭ PP; Irtuganova OA; Slogotskaia LV; Smirnova NS; Moroz AM; Borzenko AS; Spasov AA; Smirnova LA; Dzhura PI; Karpov AV; Ivanovskiĭ VB; Pauker MN; Plemiannikova GI
    Probl Tuberk; 2001; (8):29-31. PubMed ID: 11767386
    [No Abstract]   [Full Text] [Related]  

  • 45. [Determination of drug sensitivity of Mycobacterium tuberculosis by means of potassium tellurite].
    Kovalev GK
    Antibiotiki; 1969 Apr; 14(4):323-5. PubMed ID: 4977639
    [No Abstract]   [Full Text] [Related]  

  • 46. [Drug resistance of Mycobacterium tuberculosis in coniotuberculosis].
    Beskrovnyĭ PS; Varenko IuS; Lastkov OA
    Vrach Delo; 1981 Aug; (8):72-4. PubMed ID: 6791383
    [No Abstract]   [Full Text] [Related]  

  • 47. [Effect of antitubercular agents of the 2d series: ethionamide, ethoxyd cycloserine and pyrazinamide on the development of drug resistance of Mycobacterium tuberculosis to tubazide and phthivazide].
    Makeeva OO
    Farmakol Toksikol; 1969; 32(2):202-5. PubMed ID: 4977183
    [No Abstract]   [Full Text] [Related]  

  • 48. [Sensitivity to chemotherapeutic agents of Mycobacterium tuberculosis after brief stay in the organism of albino mice].
    Zueva VS; Solov'ev VN
    Antibiotiki; 1968 Apr; 13(4):355-9. PubMed ID: 4970747
    [No Abstract]   [Full Text] [Related]  

  • 49. [Experimental and clinico-therapeutic research with terizidone in tuberculosis].
    Mariani B; Bisetti A; Velluti G
    Minerva Med; 1968 May; 59(42):2445-58. PubMed ID: 5653336
    [No Abstract]   [Full Text] [Related]  

  • 50. [Studies on the susceptibility of secondary anti-tuberculosis drugs (with special reference to the resistance-stabilities of cycloserine and ethionamide-resistant bacilli)].
    Hayashi S
    Kumamoto Igakkai Zasshi; 1970 Feb; 44(2):135-43. PubMed ID: 4986047
    [No Abstract]   [Full Text] [Related]  

  • 51. Resistance to cycloserine.
    Kreis B
    Scand J Respir Dis Suppl; 1970; 71():266-78. PubMed ID: 4989517
    [No Abstract]   [Full Text] [Related]  

  • 52. [Evaluation of the therapeutic effects of secondary antitubercular agents].
    Watanabe S; Nosaki M; Iwasaki M; Hamano S; Furuya Y
    Iryo; 1966 Mar; 20(3):251-6. PubMed ID: 5965119
    [No Abstract]   [Full Text] [Related]  

  • 53. [Terminal causes of death in patients suffering from pulmonary tuberculosis in relation to the drug sensitivity of the strains of Mycobacterium tuberculosis].
    Daddi G; Lucchesi M; Mancini P; Rossi P; Sbampato M; Storniello G
    Ann Ist Carlo Forlanini; 1969; 29(4):339-48. PubMed ID: 5004332
    [No Abstract]   [Full Text] [Related]  

  • 54. [On the lability of the degree of drug resistance of Mycobacterium tuberculosis strains].
    Belogurova VP
    Antibiotiki; 1967 Aug; 12(8):718-22. PubMed ID: 4968418
    [No Abstract]   [Full Text] [Related]  

  • 55. Experiences of the cycloserine sensitivity tests performed at the second chemotherapy trial of the IUAT.
    Lind A
    Scand J Respir Dis Suppl; 1970; 71():279-84. PubMed ID: 4989518
    [No Abstract]   [Full Text] [Related]  

  • 56. [Clinical significance of Mycobacterium tuberculosis polydrug resistance in chronic destructive forms of pulmonary tuberculosis].
    Bialik IB; Klimenko MT
    Probl Tuberk; 1980 Oct; (10):68-70. PubMed ID: 6776517
    [No Abstract]   [Full Text] [Related]  

  • 57. [Influence of preservation temperature and period of media used for drug sensitivity test on minimal inhibitory concentration of D-ethambutol to the growth of mycobacterium tuberculosis].
    Tamura M; Takano S
    Kekkaku; 1969 Feb; 44(2):41-7. PubMed ID: 4977197
    [No Abstract]   [Full Text] [Related]  

  • 58. [The BCG antibiogram. Diagnostic value of resistance to cycloserine].
    Rist N; Canetti G; Boisvert H; Le Lirzin M
    Rev Tuberc Pneumol (Paris); 1967 Nov; 31(7):1060-5. PubMed ID: 4988437
    [No Abstract]   [Full Text] [Related]  

  • 59. [Observations on antituberculous drug resistance among pulmonary tuberculosis patients at the national sanatoria in Kyushu district. 4. The primary and the secondary antituberculous agents].
    Yamaguchi S
    Iryo; 1968 Oct; 22(10):1120-4. PubMed ID: 5710123
    [No Abstract]   [Full Text] [Related]  

  • 60. [Primary drug resistance of tuberculosis mycobacteria].
    Fedotova ZN; Kerpel' RS
    Probl Tuberk; 1971; 49(11):33-7. PubMed ID: 5004856
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.